These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3688024

  • 1. Linear growth response to exogenous growth hormone in Prader-Willi syndrome.
    Lee PD, Wilson DM, Rountree L, Hintz RL, Rosenfeld RG.
    Am J Med Genet; 1987 Dec; 28(4):865-71. PubMed ID: 3688024
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC, Lindberg A.
    Horm Res; 2008 Dec; 70(3):182-7. PubMed ID: 18663319
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, Ranke MB, Price DA, KIGS International Board.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [Abstract] [Full Text] [Related]

  • 4. Prader-Willi syndrome: how does growth hormone affect body composition and physical function?
    Carrel AL, Allen DB.
    J Pediatr Endocrinol Metab; 2001 Aug; 14 Suppl 6():1445-51. PubMed ID: 11837498
    [Abstract] [Full Text] [Related]

  • 5. Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency.
    Schmidt H, Bechtold S, Schwarz HP.
    Eur J Med Res; 2000 Jul 19; 5(7):307-10. PubMed ID: 10903191
    [Abstract] [Full Text] [Related]

  • 6. The Prader-Willi syndrome: a study of 40 patients and a review of the literature.
    Bray GA, Dahms WT, Swerdloff RS, Fiser RH, Atkinson RL, Carrel RE.
    Medicine (Baltimore); 1983 Mar 19; 62(2):59-80. PubMed ID: 6338343
    [Abstract] [Full Text] [Related]

  • 7. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE, Carrel AL, Whitman BY, Allen DB.
    J Pediatr; 2000 Jul 19; 137(1):42-9. PubMed ID: 10891820
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group.
    Ritzén EM, Lindgren AC, Hagenäs L, Marcus C, Müller J, Blichfeldt S.
    J Pediatr Endocrinol Metab; 1999 Apr 19; 12 Suppl 1():345-9. PubMed ID: 10698600
    [Abstract] [Full Text] [Related]

  • 9. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Sep 19; 69(3):443-51. PubMed ID: 18363884
    [Abstract] [Full Text] [Related]

  • 10. Analysis of NREM sleep in children with Prader-Willi syndrome and the effect of growth hormone treatment.
    Verrillo E, Bruni O, Franco P, Ferri R, Thiriez G, Pavone M, Petrone A, Paglietti MG, Crinò A, Cutrera R.
    Sleep Med; 2009 Jun 19; 10(6):646-50. PubMed ID: 19027358
    [Abstract] [Full Text] [Related]

  • 11. Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome.
    Höybye C.
    Acta Paediatr; 2007 Mar 19; 96(3):410-3. PubMed ID: 17407467
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
    Allen DB, Carrel AL.
    J Pediatr Endocrinol Metab; 2004 Sep 19; 17 Suppl 4():1297-306. PubMed ID: 15506076
    [Abstract] [Full Text] [Related]

  • 13. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
    Grugni G, Marzullo P, Ragusa L, Sartorio A, Trifirò G, Liuzzi A, Crinò A, Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology.
    Clin Endocrinol (Oxf); 2006 Oct 19; 65(4):492-9. PubMed ID: 16984242
    [Abstract] [Full Text] [Related]

  • 14. Early manifestations of Prader-Willi syndrome: influence of growth hormone.
    Eiholzer U, Schlumpf M, Nordmann Y, l'Allemand D.
    J Pediatr Endocrinol Metab; 2001 Oct 19; 14 Suppl 6():1441-4. PubMed ID: 11837497
    [Abstract] [Full Text] [Related]

  • 15. Body composition during GH treatment in Prader-Labhardt-Willi syndrome.
    Bosio L, Beccaria L, Benzi F, Sanzari A, Chiumello G.
    J Pediatr Endocrinol Metab; 1999 Apr 19; 12 Suppl 1():351-3. PubMed ID: 10698601
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.
    Höybye C, Hilding A, Marcus C, Thorén M.
    Growth Horm IGF Res; 2005 Dec 19; 15(6):411-5. PubMed ID: 16230042
    [Abstract] [Full Text] [Related]

  • 17. [Prader-Labhart-Willi syndrome].
    Fesseler WH, Bierich JR.
    Monatsschr Kinderheilkd; 1983 Dec 19; 131(12):844-7. PubMed ID: 6664356
    [Abstract] [Full Text] [Related]

  • 18. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M, Deal C, Van Vliet G.
    J Pediatr; 2009 Feb 19; 154(2):230-3. PubMed ID: 18814886
    [Abstract] [Full Text] [Related]

  • 19. Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome.
    Sipilä I, Sintonen H, Hietanen H, Apajasalo M, Alanne S, Viita AM, Leinonen E.
    Acta Paediatr; 2010 Nov 19; 99(11):1712-8. PubMed ID: 20545932
    [Abstract] [Full Text] [Related]

  • 20. [Growth hormone therapy in childhood. Growth hormone therapy in small children without growth hormone deficiency].
    Butenandt O.
    Fortschr Med; 1996 Jun 10; 114(16):201-4. PubMed ID: 8767930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.